Rehak V - Search Results

1

Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C.

Zeuzem S, Yoshida EM, Benhamou Y, Pianko S, Bain VG, Shouval D, Flisiak R, Rehak V, Grigorescu M, Kaita K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG. Zeuzem S, et al. Among authors: rehak v. Hepatology. 2008 Aug;48(2):407-17. doi: 10.1002/hep.22403. Hepatology. 2008. PMID: 18666223 Clinical Trial.

2

Efficacy and safety of peginterferon α-2a (40 KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe.

Urbanek P, Oltman M, Ivanovski L, Rehák V, Messinger D, Tietz A, Husa P. Urbanek P, et al. Among authors: rehak v. Eur J Gastroenterol Hepatol. 2011 Nov;23(11):1004-10. doi: 10.1097/MEG.0b013e32834b326b. Eur J Gastroenterol Hepatol. 2011. PMID: 21904204 Clinical Trial.

3

Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe.

Husa P, Oltman M, Ivanovski L, Rehák V, Messinger D, Tietz A, Urbanek P. Husa P, et al. Among authors: rehak v. Eur J Gastroenterol Hepatol. 2011 May;23(5):375-81. doi: 10.1097/MEG.0b013e3283458407. Eur J Gastroenterol Hepatol. 2011. PMID: 21502923 Clinical Trial.

4

Genotypic distribution of hepatitis B virus in the Czech Republic: a possible association with modes of transmission and clinical outcome.

Krekulova L, Rehak V, da Silva Filho HP, Zavoral M, Riley LW. Krekulova L, et al. Among authors: rehak v. Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1183-8. doi: 10.1097/00042737-200311000-00006. Eur J Gastroenterol Hepatol. 2003. PMID: 14560151

5

Hepatitis C virus (HCV) 5'NC sequence variants and their association with hepatitis C risk groups.

Krekulova L, Rehak V, Riley LW. Krekulova L, et al. Among authors: rehak v. J Clin Virol. 2005 Apr;32(4):300-4. doi: 10.1016/j.jcv.2004.08.019. J Clin Virol. 2005. PMID: 15780809

6

Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes.

Krekulova L, Rehak V, Wakil AE, Harris E, Riley LW. Krekulova L, et al. Among authors: rehak v. J Clin Microbiol. 2001 May;39(5):1774-80. doi: 10.1128/JCM.39.5.1774-1780.2001. J Clin Microbiol. 2001. PMID: 11325989 Free PMC article.

7

Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations.

Krekulova L, Rehak V, Madrigal N, Johnson M, Killoran P, Riley LW. Krekulova L, et al. Among authors: rehak v. Clin Infect Dis. 2001 Oct 15;33(8):1435-8. doi: 10.1086/323199. Epub 2001 Sep 17. Clin Infect Dis. 2001. PMID: 11565087

8

Genotypic distribution of TT virus (TTV) in a Czech population: evidence for sexual transmission of the virus.

Krekulova L, Rehak V, Killoran P, Madrigal N, Riley LW. Krekulova L, et al. Among authors: rehak v. J Clin Virol. 2001 Dec;23(1-2):31-41. doi: 10.1016/s1386-6532(01)00185-8. J Clin Virol. 2001. PMID: 11595582

9

[Distribution of HBV genotypes in the Czech population--pilot study].

Krekulová L, Rehák V, Killoran P, Zavoral M, Riley LW. Krekulová L, et al. Among authors: rehak v. Vnitr Lek. 2004 Feb;50(2):106-11. Vnitr Lek. 2004. PMID: 15077584 Czech.

10

[Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic].

Krekulová L, Rehák V, Strunecký O, Nēmecek V. Krekulová L, et al. Among authors: rehak v. Epidemiol Mikrobiol Imunol. 2009 Apr;58(2):84-9. Epidemiol Mikrobiol Imunol. 2009. PMID: 19526922 Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page